Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

Biotech Events And Company Events

Angiopoietin-1 Was Found to Has Control over Fish Brain Size and Intelligence

Angiopoietin-1 Was Found to Has Control over Fish Brain Size and Intelligence

Recently, a new study conducted by scientists at UCL, Stockholm University and University of Helsinki found that a single gene called Angiopoietin-1 (Ang-1) controls brain size and intelligence in fish. Scientists in this study employed guppies and zebra fish as models. To their

Creative BioMart Improved Its Biomarker Service

Creative BioMart Improved Its Biomarker Service

New York, May 25, 2015-Creative BioMart is pleased to announce that now it can provide improved biomarker service for drug development. Creative BioMart has been providing biomarker services for several years. The company is growing rapidly these years. And with the introduction of more advanced

Creative BioMart Launched Protein Extract Services

Creative BioMart Launched Protein Extract Services

April 21, 2015-Creative BioMart, a US influential company that aims to provide first rate biotech products and services worldwide, has launched protein extraction services this very day. In the official speaker’s words, this update is to simplify protein isolation and purification. Cell

New Findings about Plexin D1 You May Want to Know

New Findings about Plexin D1 You May Want to Know

Generally speaking, men tend to store fat in the belly while women are prone to store more fat on the hips and thighs. These actually produce the classic “apple” and “pear” shapes. According to previous studies, people who carry more weight around the bellies are more likely

Creative BioMart Launches Promotions for Proteins, Enzymes and Custom Services this New Year

Creative BioMart Launches Promotions for Proteins, Enzymes and Custom Services this New Year

On December 22, 2014, just a few days before Christmas, Creative BioMart announced that it has launched the promotion of its featured Products. This special offer will expire on 1/31/2015. This promotion is for featured proteins, enzymes and custom services. Customers can save 10% for

Garlic And Broccoli Were Found to Help Improve Cancer Treatment

Garlic And Broccoli Were Found to Help Improve Cancer Treatment

Our immune system is developed to remove things that are alien to our bodies. However. Sometimes, some types of cancer cells contain mechanisms that block the immune system’s ability to recognize them. And some stimulating molecules can over-activate the immune system and cause it to

Antibodies Were Turned into Highly Tuned Nanobodies by New Technology

Antibodies Were Turned into Highly Tuned Nanobodies by New Technology

Antibodies, one of the most useful tools in biology and medicine, play an important role in recognizing and homing in on molecular targets. Nanobodies, the tiny cousins of antibodies, can do the same work. And because of their simplicity, Nanobodies are comparatively easier to produce. Unluckily,

The Sixth PEGS Europe Will Come Next Week

The Sixth PEGS Europe Will Come Next Week

PEGS (Protein & Antibody Engineering Summit) Europe, the largest European event covering all aspects of protein and antibody engineering, will be held next week from November 3rd to 7th in Lisbon, Portugal. According to the official office, this year’s summit mainly focuses on topics

Creative BioMart Launched a Novel Service for Transcription Factor Assay

Creative BioMart Launched a Novel Service for Transcription Factor Assay

When: October 13, 2014 Where: 45-16 Ramsey Road Shirley What: Launch of new service Introduction: Creative BioMart announced today for the official release of its new service--transcription factor assay service which is backed by various of tools that can meet various of needs and

Creative BioMart Conducted a Lecture about Enzymes Market

Creative BioMart Conducted a Lecture about Enzymes Market

When: 2:00pm to 4:00pm, September 23, 2014 Where: Creative BioMart's meeting room, 45-16 Ramsey Road Shirley What: An academic lecture about enzymes market Introduction: Creative BioMart conducted an academic lecture to talk about enzymes market worldwide in the aim of having a

Biosimilars Global Congress 2014 Europe within One Week

Biosimilars Global Congress 2014 Europe within One Week

Biosimilars Global Congress 2014 Europe is going to be held in Sep 17th to Sep 19th 2014 from 8:30 am to 6:00 pm in Financial District, Boston. This Congress is to give a platform for interactive discussion and communication about practical strategies on challenges, innovations, technologies and

The 4th International Conference on Biotechnology and Environment Management 2014

The 4th International Conference on Biotechnology and Environment Management 2014

When September 15 to 16, 2014 Where Paris, France Introduction The 4th International conference on Biotechnology and Environment Management 2014 (ICBEM 2014) is a forum where innovative academics and industrial experts in the field of biotechnology and environment can get together to promote

Creative BioMart Seminar---For Downstream Processing Development

Creative BioMart Seminar---For Downstream Processing Development

August 12, 2014---Creative BioMart launched a seminar to discuss the development of downstream processing. Participants include Creative BioMart staff scientists and sale staff. Holding this seminar, Creative BioMart wants to expand the service for downstream processing. Downstream processing is

Creative BioMart Launches Promotion Activity for Featured Recombinant Proteins This August

Creative BioMart Launches Promotion Activity for Featured Recombinant Proteins This August

Creative BioMart Launches Promotion Activity for Featured Recombinant Proteins This August

Statistics: Research Focus Is Put on Recombinant Proteins

Statistics: Research Focus Is Put on Recombinant Proteins

According to the results of one of our online surveys, most listed companies have placed their emphasis on the development of recombinant proteins. Meanwhile according to the statistics of financial weekly newspaper, nine pharmaceutical companies have mentioned that they have made

Big Shuffle in Pharmaceutical Industry: New Round of GMP Certification Creates Chance for Company Acquisition

Big Shuffle in Pharmaceutical Industry: New Round of GMP Certification Creates Chance for Company Acquisition

According to China Food and Drug Administration (CFDA) report, as of December 31, 2013, more than seven hundreds of enterprises in sterile pharmaceutical manufacture in China have approved the newly revised GMP certification, however, more than four hundreds of others failed and fallen into

Drug Company Concern: Trend in Pharmaceutical Information

Drug Company Concern: Trend in Pharmaceutical Information

On January 3rd, the Public Accounts Committee, British House of Commons published a report with regard to the reservation issue of Tamiflu (a kind of influenza drug that is usually used in the treatment of both seasonal flu and swine flu), which sparked a discussion about whether the clinical

2013 Year in Review: Creative BioMart’s Scientific Expertise in Recombinant Protein Production

2013 Year in Review: Creative BioMart’s Scientific Expertise in Recombinant Protein Production

It’s the time for the 2013 year in review for Creative BioMart considering the physical time is coming. We’d love to share the experience with you. The production of recombinant proteins can be a tricky process that consumes time, manpower and money. Therefore specialized

Worldwide Biotech/Biopharma Alliance (Dec. 20 – Dec. 19)

Worldwide Biotech/Biopharma Alliance (Dec. 20 – Dec. 19)

On Dec. 20, 2013, PeptiDream Inc announced that they have entered into a Collaboration and License Agreement with US-based Eli Lilly and Company (Lilly) (LLY). Under the agreement, PeptiDream will identify macrocyclic peptides as potential drug candidates for disease targets being pursued by Lilly.

EU Regulatory: Giant Pharmaceuticals Are Fined Again for Disorganizing Market

EU Regulatory: Giant Pharmaceuticals Are Fined Again for Disorganizing Market

On last Tuesday, EU regulators announced another pecuniary penalty event on pharmaceutical giant Johnson & Johnson and Novartis because they tried to stop the selling launch of a cheaper painkiller biosimilar. They have to accept a fine of €16.3 million (i.e. $ 22 million); meanwhile

Creative BioMart “Morning Talk”: Give Answers to Diagnostic Enzymes

Creative BioMart “Morning Talk”: Give Answers to Diagnostic Enzymes

Generally speaking, enzymes used for clinical purpose or intended metabolic investigation are diagnostic enzymes. Examples of diagnostic enzymes include Adenosine Aminohydrolase (ADA), Neuron Specific Enolase (NSE), Catalase (CAT), Glucose Oxidase (GOD), Glycerol Kinase (GK/GYK), Malate

Broader Portfolio of Recombinant Antibodies Launched by Creative BioMart

Broader Portfolio of Recombinant Antibodies Launched by Creative BioMart

Creative BioMart, a world leader in immunoassay development and contract manufacturing, expanded its unique range of Recombinant Antibodies at the Clinical Lab Expo. Antibodies are vital research tools for cell biology and biomedical research. But it is generally difficult to access

Creative BioMart Updates New Product—Thrombin

Creative BioMart Updates New Product—Thrombin

Creative BioMart will update its products on a daily basis. This time, the thrombin is “on the shelf” and intended customers are accessible to purchase and inquire related information by contacting out experts. Or some of necessary information can be found on our official website.

Retrospective Viewpoint: Biotechnology Companies Keep Going with Mergers

Retrospective Viewpoint: Biotechnology Companies Keep Going with Mergers

In face of patent expiration or other threats, big pharmaceutics are facing challenges too. In priority, innovative technology or novel developments are necessary. On 2010, Celgene declared the acquisition of ABII for $2.9 billion for cancer treatment. On May 2011, Shire declared the

Worldwide BiotechBiopharma Alliance within the Two Days

Worldwide BiotechBiopharma Alliance within the Two Days

On Nov. 14, 2013, MRC Technology announced that it is collaborating with Dr Zameel Cader at Oxford University’s Nuffield Department of Clinical Neurosciences, to screen selective and potent potassium channel activators to develop novel therapeutic interventions in migraine. On Nov. 13,

logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends